智能肿瘤学（英文）（Intelligent Oncology）（国际刊号）

期刊简介

《智能肿瘤学（英文）（Intelligent Oncology）（国际刊号）》期刊已被查看： 次

更新频次

单位占比

一作占比

投稿指南

1、该刊只有国际刊号！

2、投稿方式：在线投稿。

3、官网网址：http://www.china-pharmacy.com/526

https://www.keaipublishing.com/en/journals/intelligent-oncology/

4、投稿系统：

https://www2.cloud.editorialmanager.com/intonc/default2.aspx

5、出刊日期：季刊，逢季末月出版。

2023年10月10星期二

Intelligent Oncology医工交叉国际学术期刊获得 ISSN

【微信公众号“智能肿瘤学（intelligentoncology）”信息】

智能肿瘤学 智能肿瘤学 2023-07-07 16:37发表于重庆

由重庆大学主办，重庆大学附属肿瘤医院和重庆大学医学院承办的医工交叉国际学术期刊——Intelligent Oncology已获得 ISSN，Electronic·ISSN:2950-2616。

Intelligent Oncology以智能肿瘤学科为核心主题，致力于发布高质量的原创性研究、综述和评论，通过汇集这一多学科领域最重要的进展，促进临床肿瘤学、信息科学、数学等多学科融合的理论与应用研究。稿源方向包括肿瘤人工智能技术的基础理论与临床肿瘤学研究应用、智能肿瘤学临床试验、药物研发等。包括医学、药学、工学和理学在肿瘤诊疗中的相关研究。本刊具有广泛的选稿和组稿范围，为肿瘤人工智能相关理论研究和临床诊疗应用研究提供成果分享和总结交流平台。

Introduction to Intelligent Oncology

Intelligent Oncology (ISSN2950-2616) is an international academic journal sponsored by Chongqing University, managed by Chongqing University Cancer Hospital, and published in collaboration with the KeAi Publishing Group，jointly founded by Elsevier and China Science Publishing & Media Ltd. The journal is quarterly published in the form of open access (OA).

Led by an elite group of physician scientists, computer engineers and cancer researchers, Intelligent Oncology is positioned as a world leading academic journal to disseminate the concept of the newly developed and integrated discipline of intelligent oncology, the combination of artificial intelligence and clinical oncology. The founding editor-in-chief of the journal is Professor Bo Xu, President of Chongqing University Cancer Hospital. Co-editors of the journal are Professor Wenli Cai of Harvard University School of Medicine and Massachusetts General Hospital, and Professor Fengming Spring Kong of Hong Kong University. The editorial board includes 40 members of seasoned physicians, scientists and engineers.

Intelligent Oncology is an interdisciplinary academic journal of oncology and computer sciences, with intelligent oncology as the core theme. It is committed to publishing high-quality original research, reviews, comments and perspectives. By collecting the most important progresses in this multidisciplinary field, it promotes the theoretical and applied research on the integration of clinical oncology, information science, mathematics and other subjects. Subjects considered for publication include but are not limited to artificial intelligence technology, algorithm construction, applications of AI technology in exploratory and clinical setting, AI-assisted clinical trials, AI-based drug discovery and development. The column settings of Intelligent Oncology include editor's notes, perspectives, comments, original articles, reviews, and expert consensus.

Call for papers投稿须知

【微信公众号信息】

Editorial Office 智能肿瘤学 2023-09-26 10:07 发表于重庆

Intelligent Oncology invites you to contribute your research findings and opinions converging the fields of oncology and computer science. The journal is dedicated to publishing innovative original research, reviews, commentaries, and perspectives in the new area of intelligent oncology. It serves as a platform to advance both theoretical and applied research integrating oncology, information science, mathematics among other fields.

Subjects considered for publication include, but are not limited to:

·Artificial intelligence technology

·AI research and application in clinical oncology

·Innovative Algorithms and Interpretability

·AI-guided clinical trials

·AI-driven drug discovery and development

·Digital Pathology

·Digital Radiology

·Multi-modal Learning

·AI in cancer research

Why publish in Intelligent Oncology?

·Rapid publication. We offer the fastest possible publication speed without compromising on peer -eview quality.

·All articles are published open access, so are immediately free to download and share from the moment of publication.

·An expert and dedicated international editorial board will give your research the attention it deserves.

·You can reach a global audience. More than 17 million academic and industry-based readers and authors visit ScienceDirect each month.

Requirements:

·Send a full paper for review.

·The submitted papers should be original and have not been published elsewhere.

·All submissions must be written in English.

Please visit our website at https://www.keaipublishing.com/en/journals/intelligent-oncology/to submit your paper. If you have any questions or concerns, please feel free to contact us (E-mail: EditorialOffice@intelligent-oncology.net).

We look forward to receiving your submissions.

Guide for Authors投稿指南

【官网信息】

Instructions for Authors

INTRODUCTION

Types of paper

Full-length/ Research Article(Word limit: 5000-7000)

A complete report on original research and/or clinical studies.

A structured abstract is required.

A clear structure is required, which should contain but not confined to the following sections:

Introduction

Material and methods

Results

Discussion

Conclusions

Authors' contribution (For details please visit the link.)

Ethic statement

COI

(acknowledgments/clarification)

Bibliography

Appendices (including multimedia components)

Review Article (Word limit: 7000-9000)

A substantial overview presents a complete overview of the state of the art with a comprehensive bibliography, generally, also contains a table of contents. It should cover topics that have seen significant development or progress in recent years, with comprehensive depth and a balanced perspective. Review articles should NOT include unpublished material such as unpublished/original data, submitted manuscripts, or personal communication.

Editorial(Word limit: 1000)

Generally from the (guest) editor of the publication. Can be Foreword, Editorial, Guest Editorial, Preface, etc.

Short Communication (Word limit: 2000)

Short report or announcement of research, usually claiming certain results, which present original and significant material for rapid dissemination. Short Communications are expected to have a higher than average impact on the field rather than report on incremental research.

Guideline/Consensus (Word limit: 10000)(for clinical medicine only)

Guidelines: Documents that have been locally or internationally approved and contain general principles that may benefit others in their clinical practice or in writing their own guidelines.

Consensus: Evidence-based analyses of issues that integrate findings, ideas and/or conceptual frameworks from a variety of sources in a clear and balanced way.

Meeting Reports, News and Announcements (Word limit: 1500)

Meeting reports Summary of a relevant symposium, workshop, etc. Or, information about a conference (can be a description of the venture, but also a visit report of a scientist who has attended a conference).

Letter to the Editor (Word limit: 2,000)

Any items of interest to the wide audience of the publication. The items include a letter to the editor commenting on previously published articles or a reply to the letter. (The letter or reply needs a 'refers-to' DOI or PII number; or argumentative communication, like papers in a discussion, or commentaries, etc.(Subsequent discussion papers need a 'refers-to' DOI or PII number).

……

更多详情：

https://www.keaipublishing.com/en/journals/intelligent-oncology/guide-for-authors/